Extended spectrum beta lactamase producing escherichia coli and klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes

Journal of Association of Physicians of India

Volumn 58, Issue SUPPL DEC2010, 2010, Pages 41-44

  Shanthi, M ^a   Sekar, Uma ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BIOSYNTHESIS; CROSS INFECTION; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; HOSPITALIZATION; HUMAN; INDIA; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PREVALENCE; RISK FACTOR; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; INDIA; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960045739     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Philip J Turner.Extended Spectrum β-Lactamases. Clin Infect Dis 2005;41:S273-75.
2. David L Paterson and Robert A Bonomo. Extended-Spectrum β-Lactamases: a Clinical Update. Clin Microbiol Rev 2005;18:657-686
3. George A Jacoby. Amp C β-lactamases. Clin Microbiol Rev 2009;22:161-182
4. Mario Tumbarello, Teresa Spanu, Maurizio Sanguinetti et al. Bloodstream infections caused by Extended-spectrum β-lactamase producing Klebsiella pneumoniae: Risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 2006;50:498-504
5. Michael A Pfaller, John Segreti. Overview of the epidemiological profile and laboratory detection of Extended Spectrum β-lactamases. Clin Infect Dis 2006;42:S153-63
6. Su Young Lee, Srividya Kotapati, Joseph L Kuti et al. Impact of Extended-Spectrum β-Lactamase-producing Escherichia coli and Klebsiella Species on clinical outcomes and hospital costs: A matched cohort study. Infect Control Hosp Epidemiol 2006;27:1226-1232.
7. Mitchell J Schwaber, Shiri Navon-Venezia, Keith S Kaye et al. Clinical and economic Impact of bacteremia with extended spectrum-β-Lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006;50:1257-1262.
8. Ebbing Lautenbach, Jean Baldus Patel, Warren B Bilker. Extended-Spectrum β-Lactamase producing Escherichia coli and Klebsiella pneumoniae:Risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162-71
9. Clinical Laboratory Standard Institute 2006. Performance standards for antimicrobial susceptibility testing; Sixteenth informational supplement-document M100-S19.Clinical Laboratory Standard Institute. Wayne, PA
10. Bonnet R. Growing group of Extended-Spectrum β-Lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004;48:1-14
11. Naas T, Poirel L and Nordmann P. Minor extended-spectrum β-lactamases. Clin Microbiol Infect 2008;14(Suppl. 1):42-52.
12. Varsha Gupta. An update on newer β-lactamases. Indian J Med Res 2007;126:417-427
13. Karen Bush and George A Jacoby. An updated functional classification of β-lactamases. Antimicrob Agents Chemother 2009;doi:10.1128/AAC.01009-09.
14. Thomas G Slama. Gram-negative antibiotic resistance: there is a price to pay.Critical Care 2008,12(Suppl 4):S4.
15. Gregory Bisson, Neil O Fishman, Jean Baldus Patel, Paul H Edelstein, Ebbing Lautenbach. Extended-Spectrum _-Lactamase-producing Escherichia Coli and Klebsiella Species:Risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidemiol 2002;23:254-260.
16. Darren R Linkin, Neil O Fishman, Jean Baldus Patel, Jeffrey D Merrill, Ebbing Lautenbach. Risk Factors for Extended-Spectrum Beta-Lactamase producing Enterobacteriaceae in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2004;25:781-783.
17. Lucet JC, Chevret S, Decre D, Vanjak D, Macrez A, Bedos JP, Wolff M and Regnier B. Control of a prolonged outbreak of extendedspectrum beta-lactamase producing Enterobacteriaceae in a university hospital. Clin Infect Dis 1996;22:430-436.
18. Emily S Bomsang and Myrna T Mendoza. Prevalence and risk factors associated with extended spectrum beta lactamase (ESBL) production among selected Enterobacteriaceae isolates at the Philippine General Hospital. Philippine Journal of Microbiology and Infectious Disease 2003;32.
19. Warren RE, Harvey G, Carr R et al. Control of infections due to extended spectrum β -lactamase producing organisms in hospitals and the community. Clin Microbiol Infect 2008;14(Suppl 1):124-133.